Business Update27 Oct 2025, 03:09 pm
SRF Ltd. Approves Revised Capex of Rs. 745 Crores for Specialty Fluoropolymers Production
AI Summary
SRF Ltd. has announced a revised capital expenditure proposal of Rs. 745 Crores, approved by the Board, for the production of a range of Specialty Fluoropolymers. This revised capex is a result of strategic agreements entered into with The Chemours Company for manufacturing, supply, and distribution of certain fluoropolymers and fluoroelastomers. The added capacity is expected to be operational by December 2026, and will be financed through a mix of debt and internal accruals. The rationale behind this investment is to meet the customer demand.
Key Highlights
- SRF Ltd. approves revised capex of Rs. 745 Crores for Specialty Fluoropolymers production.
- Capex revision necessitated due to strategic agreements with The Chemours Company.
- Added capacity to be operational by December 2026.
- Financing to be through a mix of debt and internal accruals.
- Investment aimed at meeting customer demand.